Humana Inc: Form 10-K for the period ended Dec 31, 2016
Filed with the SEC on Feb 17, 2017 and accepted by EDGAR at Feb 17, 2017, 08:40 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2016-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2016-10-01 to 2016-12-31 | $12.88bn | us-gaap:Revenues |
| Revenue | 12 months2016-01-01 to 2016-12-31 | $54.38bn | us-gaap:Revenues |
| Selling, general and administrative | 12 months2016-01-01 to 2016-12-31 | $7.28bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2016-01-01 to 2016-12-31 | $1.74bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2016-01-01 to 2016-12-31 | $189.0m | us-gaap:InterestExpense |
| Income tax | 12 months2016-01-01 to 2016-12-31 | $938.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2016-10-01 to 2016-12-31 | −$401.0m | us-gaap:NetIncomeLoss |
| Net income | 12 months2016-01-01 to 2016-12-31 | $614.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2016-10-01 to 2016-12-31 | −$2.68 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 12 months2016-01-01 to 2016-12-31 | $4.07 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2016-10-01 to 2016-12-31 | −$2.68 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 12 months2016-01-01 to 2016-12-31 | $4.11 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2016-01-01 to 2016-12-31 | 150,917,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2016-01-01 to 2016-12-31 | $1.94bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2016-01-01 to 2016-12-31 | $527.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months2016-01-01 to 2016-12-31 | $177.0m | us-gaap:PaymentsOfDividends |
| Share repurchases | 12 months2016-01-01 to 2016-12-31 | $104.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2016-12-31 | $3.88bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2016-12-31 | $16.19bn | us-gaap:AssetsCurrent |
| Total assets | At period end2016-12-31 | $25.40bn | us-gaap:Assets |
| Current liabilities | At period end2016-12-31 | $7.82bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2016-12-31 | $14.71bn | us-gaap:Liabilities |
| Long-term debt | At period end2016-12-31 | $3.79bn | us-gaap:LongTermDebtNoncurrent |
| Short-term borrowings | At period end2016-12-31 | $300.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2016-12-31 | $10.69bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000049071-17-000019. Last ingested by Listed: Nov 10, 2026, 18:12 ET. Listed shows no prices and gives no investment advice.